Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 186-191 , July 2007

Forecasting the global burden of Alzheimer’s disease

  • Ron Brookmeyer

      Affiliations

    • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    • Corresponding Author InformationCorresponding author. Tel.: 410-955-3519.
    • ,
  • Elizabeth Johnson

      Affiliations

    • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    • ,
  • Kathryn Ziegler-Graham

      Affiliations

    • Statistics Program, St. Olaf College, Northfield, MN, USA
    • ,
  • H. Michael Arrighi

      Affiliations

    • Epidemiology, Elan Pharmaceuticals, San Diego, CA, USA

References 

  1. Roberson E, Mucke L. 100 years and counting: prospects for defeating Alzheimer’s disease. Science. 2006;314:781–784
  2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Gunguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117
  3. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337–1342
  4. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World population prospects. Available at http.//esa.un.org/unpp.
  5. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728–733
  6. Neumann PJ, Araki SS, Arcelus A, Longo G, Papadopoulos KS, Kosik KM, et al. Measuring Alzheimer’s disease progression with transition probabilities: estimates from CERAD. Neurology. 2001;57:957–964
  7. Stern Y, Tang X, Albert MS, Brandt J, Jacobs DM, Bell K, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;277:806–812
  8. Guehne U, Riedel-Heller S, Angermeyer M. Mortality in dementia. Neuroepidemiology. 2005;25:153–162
  9. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501–509
  10. Brookmeyer R, Corrada M, Curriero F, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59:1764–1767
  11. Human Mortality Database. University of California, Berkeley (USA) and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (data downloaded on 12/06/2005).
  12. Wimo A, Winblad B, Aguero-Torres H, Strauss E. The magnitude of dementia occurrence in the world (2003). Alzheimer Dis Assoc Disord. 2003;17:63–67
  13. Alzheimer’s Association. Alzheimer’s disease facts and figures 2007. Chicago; 2007. Available at: www.alz.org.
  14. Sloane PD, Zimmerman SZ, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health. 2002;23:213–231
  15. Hy LX, Keller DM. Prevalence of Alzheimer’s disease among whites: a summary by level of severity. Neurology. 2000;55:198–204
  16. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer’s disease in a retirement community. Am J Epidemiol. 1987;125:420–436
  17. Rorsman B, Hagnell O, Lanke J. Prevalence and incidence of senile and multi-infarct dementia in the Lunby Study: a comparison between the time periods 1947–1957 and 1957–1972. Neuropsychobiology. 1986;15:122–129
  18. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Computer software to forecast the global burden of Alzheimer’s disease. Available at http.//www.biostat.jhsph.edu/project/globalAD/index.htm.
  19. Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord. 2006;21:175–181
  20. Pope SK, Shue VM, Beck C. Will a healthy lifestyle prevent Alzheimer’s disease?. Annu Rev Public Health. 2003;24:111–132

 Conflict of interest: H.M.A. is Director of Epidemiology at Elan Pharmaceuticals, a sponsor of the study.

PII: S1552-5260(07)00475-X

doi: 10.1016/j.jalz.2007.04.381

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 3 , Pages 186-191 , July 2007

Article Tools

* Image Usage & Resolution